Cargando…
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study
BACKGROUND: Palmoplantar pustulosis (PPP) is a pruritic, painful, recurrent, and chronic dermatitis with limited therapeutic options. OBJECTIVE: To evaluate the efficacy and safety of apremilast for the treatment of Japanese patients with PPP and inadequate response to topical treatment. METHODS: Th...
Autores principales: | Terui, Tadashi, Okubo, Yukari, Kobayashi, Satomi, Sano, Shigetoshi, Morita, Akimichi, Imafuku, Shinichi, Tada, Yayoi, Abe, Masatoshi, Yaguchi, Masafumi, Uehara, Natsuka, Handa, Takahiro, Tanaka, Masayuki, Zhang, Wendy, Paris, Maria, Murakami, Masamoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213585/ https://www.ncbi.nlm.nih.gov/pubmed/37233897 http://dx.doi.org/10.1007/s40257-023-00788-2 |
Ejemplares similares
-
Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical Trial
por: Terui, Tadashi, et al.
Publicado: (2019) -
Apremilast monotherapy for palmoplantar pustulosis: Report of three cases
por: Marovt, Maruška, et al.
Publicado: (2021) -
Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis
por: Spencer, Riley K., et al.
Publicado: (2023) -
Beneficial Impact of Apremilast on Palmoplantar Keratodermas
por: NAKAJIMA, Kimiko, et al.
Publicado: (2021) -
Immediate response to apremilast in patients with palmoplantar pustulosis: a retrospective pilot study
por: Kato, Noriko, et al.
Publicado: (2021)